CSIMarket Company Name, Ticker, Industry, else..
 
Applied Therapeutics Inc   (NASDAQ: APLT)
 

Applied Therapeutics Inc's Suppliers Performance

APLT's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
APLT Costs vs Sales of Suppliers Growth

• More on APLT Suppliers






Applied Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, drug substances, and drug products for preclinical research and clinical trials of AT-007, AT-001, and AT-003 from contract manufacturing organizations (CMOs). It has not entered into long-term agreements with current CMOs but plans to continue relying on them for later-stage development and commercialization. The synthesis of drug substances for AT-007 and AT-001 is considered reliable and scalable using readily available starting materials. Drug product formulation development for AT-007 and AT-001 is complete, and the company has contracted a third-party manufacturer for formulation development and drug product manufacturing through commercialization. The company may add a second drug product manufacturer in the future to increase capacity and supply chain redundancy. Personnel and third-party consultants with manufacturing experience oversee relationships with contract manufacturers.

Applied Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, drug substances, and drug products for preclinical research and clinical trials of AT-007, AT-001, and AT-003 from contract manufacturing organizations (CMOs). It has not entered into long-term agreements with current CMOs but plans to continue relying on them for later-stage development and commercialization. The synthesis of drug substances for AT-007 and AT-001 is considered reliable and scalable using readily available starting materials. Drug product formulation development for AT-007 and AT-001 is complete, and the company has contracted a third-party manufacturer for formulation development and drug product manufacturing through commercialization. The company may add a second drug product manufacturer in the future to increase capacity and supply chain redundancy. Personnel and third-party consultants with manufacturing experience oversee relationships with contract manufacturers.







APLT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Applied Therapeutics Inc 15.02 0.46 -18.14 80
SUBTOTAL 0.00 0.00 0.00 -


Sources: Applied Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Applied Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.